发明公开
EP0430025A2 Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
失效
黄嘌呤化合物,涉及它们的制备和含有它们的药物制剂的方法。
- 专利标题: Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
- 专利标题(中): 黄嘌呤化合物,涉及它们的制备和含有它们的药物制剂的方法。
-
申请号: EP90122146.5申请日: 1990-11-20
-
公开(公告)号: EP0430025A2公开(公告)日: 1991-06-05
- 发明人: Ito, Yasuo , Kato, Hideo , Koshinaka, Eiichi , Yagi, Noriyuki , Iwasaki, Nobuhiko
- 申请人: HOKURIKU PHARMACEUTICAL CO., LTD.
- 申请人地址: 1-Chome, 3-14, Tatekawacho, Katsuyama-shi Fukui-ken 911 JP
- 专利权人: HOKURIKU PHARMACEUTICAL CO., LTD.
- 当前专利权人: HOKURIKU PHARMACEUTICAL CO., LTD.
- 当前专利权人地址: 1-Chome, 3-14, Tatekawacho, Katsuyama-shi Fukui-ken 911 JP
- 代理机构: Werner, Hans-Karsten, Dr.Dipl.-Chem.
- 优先权: JP303362/89 19891124; JP166720/90 19900627
- 主分类号: C07D473/06
- IPC分类号: C07D473/06 ; A61K31/52
摘要:
A novel xanthine compound having bronchodilating and brain function improving activity represented by the following formula (I) and (II):
wherein R¹ represents a hydrogen atom, 4-methoxybenzyl group, a straight- or branched-chain alkyl group having 1 to 6 carbon atoms, or a cycloalkyl group having 3 to 6 carbon atoms; R² represents a hydrogen atom, a straight- or branched-chain alkyl group having 1 to 6 carbon atoms, or a cycloalkyl group having 3 to 6 carbon atoms; n represents an integer of from 1 to 4; and A represents -COCH₃ or - C(OR³)(OR⁴)CH₃ in which R³ and R⁴ independently represents an alkyl group having 1 to 3 carbon atoms or R³ together with R⁴ represents a polymethylene group having 2 to 4 carbon atoms is disclosed. Also disclosed are a pharmacologically acceptable salt of the same, method for preparing the same, and a pharmaceutical composition for the treatment of respiratory tract disease or brain disfunction comprising the effective amount of same.
wherein R¹ represents a hydrogen atom, 4-methoxybenzyl group, a straight- or branched-chain alkyl group having 1 to 6 carbon atoms, or a cycloalkyl group having 3 to 6 carbon atoms; R² represents a hydrogen atom, a straight- or branched-chain alkyl group having 1 to 6 carbon atoms, or a cycloalkyl group having 3 to 6 carbon atoms; n represents an integer of from 1 to 4; and A represents -COCH₃ or - C(OR³)(OR⁴)CH₃ in which R³ and R⁴ independently represents an alkyl group having 1 to 3 carbon atoms or R³ together with R⁴ represents a polymethylene group having 2 to 4 carbon atoms is disclosed. Also disclosed are a pharmacologically acceptable salt of the same, method for preparing the same, and a pharmaceutical composition for the treatment of respiratory tract disease or brain disfunction comprising the effective amount of same.
公开/授权文献
信息查询